Skip links

Ofev® (nintedanib)

Full Name Ofev® (nintedanib)
Drug Ofev
Manufacturer Boehringer Ingelheim
Route of Administration Oral
Site of Care Home
Approved Indication Treatment of idiopathic pulmonary fibrosis (IPF) in adults, treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype in adults, or slowing the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD)
Disease Idiopathic Pulmonary Fibrosis (IPF); Systemic Sclerosis Interstitial Lung Disease (SSc-ILD)
Therapeutic Area Pulmonology
Enrollment Form Link Ofev Enrollment Form
Phone Number 800-373-1452
Fax Number 888-975-1456
Product Website